Page 41 - AN-4-2

Advanced Neurology SARS-CoV-2 mechanisms of neurological impact

doi: 10.1016/j.nbd.2020.105131 143. Wahis J, Hennes M, Arckens L, Holt MG. Star power: The
emerging role of astrocytes as neuronal partners during
133. Perico L, Benigni A, Remuzzi G. SARS-CoV-2 and the spike
protein in endotheliopathy. Trends Microbiol. 2024;32(1):53‑67. cortical plasticity. Curr Opin Neurobiol. 2021;67:174‑182.
doi: 10.1016/j.conb.2020.12.001
doi: 10.1016/j.tim.2023.06.004
144. Murphy-Royal C, Dupuis J, Groc L, Oliet SHR. Astroglial
134. Crunfli F, Carregari VC, Veras FP, et al. Morphological,
cellular, and molecular basis of brain infection glutamate transporters in the brain: Regulating
in COVID-19 patients. Proc Natl Acad Sci U S A. neurotransmitter homeostasis and synaptic transmission.
2022;119(35):e2200960119. J Neurosci Res. 2017;95(11):2140‑2151.
doi: 10.1073/pnas.2200960119 doi: 10.1002/jnr.24029
135. Steardo L Jr., Steardo L, Scuderi C. Astrocytes and the 145. Nakaso K. Roles of microglia in neurodegenerative diseases.
psychiatric sequelae of COVID‑19: What we learned from Yonago Acta Med. 2024;67(1):1‑8.
the pandemic. Neurochem Res. 2023;48(4):1015‑1025. doi: 10.33160/yam.2024.02.001
doi: 10.1007/s11064-022-03709-7 146. Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative
136. Zalpoor H, Akbari A, Samei A, et al. The roles of Eph diseases: Mechanism and potential therapeutic targets.
receptors, neuropilin-1, P2X7, and CD147 in COVID-19- Signal Transduct Target Ther. 2023;8(1):359.
associated neurodegenerative diseases: Inflammasome and doi: 10.1038/s41392-023-01588-0
JAK inhibitors as potential promising therapies. Cell Mol
Biol Lett. 2022;27(1):10. 147. Long HZ, Zhou ZW, Cheng Y, et al. The role of microglia
in Alzheimer’s disease from the perspective of immune
doi: 10.1186/s11658-022-00311-1 inflammation and iron metabolism. Front Aging Neurosci.
137. Madden N, Mei YZJ, Jakubiak K, et al. The link between 2022;14:888989.
SARS-CoV-2 related microglial reactivity and astrocyte doi: 10.3389/fnagi.2022.888989
pathology in the inferior olivary nucleus. Front Neurosci.
2023;17:1198219. 148. Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer’s
disease. J Cell Biol. 2018;217(2):459‑472.
doi: 10.3389/fnins.2023.1198219
doi: 10.1083/jcb.201709069
138. Stanca S, Rossetti M, Bongioanni P. Astrocytes as
neuroimmunocytes in Alzheimer’s disease: A biochemical 149. Abate G, Memo M, Uberti D. Impact of COVID-19 on
tool in the neuron-glia crosstalk along the pathogenetic Alzheimer’s disease risk: Viewpoint for research action.
pathways. Int J Mol Sci. 2023;24(18):13880. Healthcare (Basel). 2020;8(3):286.
doi: 10.3390/ijms241813880 doi: 10.3390/healthcare8030286
139. Lyra ESN, Barros-Aragao FGQ, De Felice FG, Ferreira ST. 150. Chiricosta L, Gugliandolo A, Mazzon E. SARS-CoV-2
Inflammation at the crossroads of COVID-19, exacerbates beta-amyloid neurotoxicity, inflammation and
cognitive deficits and depression. Neuropharmacology. oxidative stress in Alzheimer’s disease patients. Int J Mol Sci.
2022;209:109023. 2021;22(24):13603.
doi: 10.1016/j.neuropharm.2022.109023 doi: 10.3390/ijms222413603
140. Tahira AC, Verjovski‑Almeida S, Ferreira ST. Dementia is an 151. Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid beta‑
age-independent risk factor for severity and death in COVID- based therapy for Alzheimer’s disease: Challenges, successes
19 inpatients. Alzheimers Dement. 2021;17(11):1818‑1831. and future. Signal Transduct Target Ther. 2023;8(1):248.
doi: 10.1002/alz.12352 doi: 10.1038/s41392-023-01484-7
141. Foley KE, Winder Z, Sudduth TL, et al. Alzheimer’s 152. Navolokin N, Adushkina V, Zlatogorskaya D, et al.
disease and inflammatory biomarkers positively correlate Promising strategies to reduce the SARS-CoV-2 amyloid
in plasma in the UK-ADRC cohort. Alzheimers Dement. deposition in the brain and prevent COVID-19-exacerbated
2024;20(2):1374‑1386. dementia and Alzheimer’s disease. Pharmaceuticals (Basel).
2024;17(6):788.
doi: 10.1002/alz.13485
doi: 10.3390/ph17060788
142. Shajahan SR, Kumar S, Ramli MDC. Unravelling
the connection between COVID-19 and Alzheimer’s 153. Poloni TE, Medici V, Moretti M, et al. COVID-19-related
disease: A comprehensive review. Front Aging Neurosci. neuropathology and microglial activation in elderly with
2023;15:1274452. and without dementia. Brain Pathol. 2021;31(5):e12997.
doi: 10.3389/fnagi.2023.1274452 doi: 10.1111/bpa.12997

Volume 4 Issue 2 (2025) 35 doi: 10.36922/an.4909